Multiple actions of phenytoin on mouse spinal cord neurons in cell culture

MJ McLean and RL Macdonald

Concentration-dependence of multiple actions of phenytoin (PT) on mouse spinal cord neurons in primary dissociated cell culture was studied using intracellular microelectrode recording techniques. At concentrations of 2 to 50 micrograms/ml, PT did not alter resting membrane potential or input resistance. At 1 to 2 micrograms/ml, equivalent to therapeutic cerebrospinal fluid concentrations, PT limited the ability to sustain high-frequency repetitive firing of action potentials during long (500-2000 msec) depolarizing current pulses. There was a progressive reduction of maximal rate of rise (Vmax) of action potentials during the train until firing failed. Recovery of Vmax of single action potentials after repetitive firing was also prolonged. PT did not reduce Vmax of a single action potential at 1 to 2 micrograms/ml, but did so at 3 to 40 micrograms/ml in a voltage-dependent manner. Hyperpolarization partially reversed this reduction of Vmax. Thus, PT may slow recovery of sodium channels from inactivation. At concentrations above 3 micrograms/ml, PT reduced spontaneous neuronal firing with progressive increase in the number of quiescent neurons, reduced calcium-dependent action potential duration and amplitude, eradicated convulsant-induced paroxysmal bursting and augmented postsynaptic responses to iontophoretically applied gamma- aminobutyric acid. Glutamic acid responses were unaffected at PT concentrations of 10 micrograms/ml or less. These actions occurred at concentrations equivalent to toxic cerebrospinal fluid levels in patients and may be related to PT-induced toxicity. We suggest that limitation of sustained high-frequency repetitive firing may account, at least in part, for the anticonvulsant efficacy of PT.

Volume 227, Issue 3, pp. 779-789, 12/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				R. Surges, K. E. Volynski, and M. C. Walker Review: Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 13 - 24. [Abstract] [PDF]

				A. C. Errington, T. Stohr, C. Heers, and G. Lees The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium Channels Mol. Pharmacol., January 1, 2008; 73(1): 157 - 169. [Abstract] [Full Text] [PDF]

				C. Yvon, A. Czarnecki, and J. Streit Riluzole-Induced Oscillations in Spinal Networks J Neurophysiol, May 1, 2007; 97(5): 3607 - 3620. [Abstract] [Full Text] [PDF]

				A. C. Lo, C. Y. Saab, J. A. Black, and S. G. Waxman Phenytoin Protects Spinal Cord Axons and Preserves Axonal Conduction and Neurological Function in a Model of Neuroinflammation In Vivo J Neurophysiol, November 1, 2003; 90(5): 3566 - 3571. [Abstract] [Full Text] [PDF]

				D. Kuebler, H. Zhang, X. Ren, and M. A. Tanouye Genetic Suppression of Seizure Susceptibility in Drosophila J Neurophysiol, September 1, 2001; 86(3): 1211 - 1225. [Abstract] [Full Text] [PDF]

				E. H. Sinz, W. A. Kofke, and R. H. Garman Phenytoin, Midazolam, and Naloxone Protect Against Fentanyl-Induced Brain Damage in Rats Anesth. Analg., December 1, 2000; 91(6): 1443 - 1449. [Abstract] [Full Text] [PDF]

				P. Calabresi, B. Picconi, E. Saulle, D. Centonze, A. H. Hainsworth, G. Bernardi, and G. Z. Feuerstein Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release? • Editorial Comment Stroke, March 1, 2000; 31(3): 766 - 773. [Abstract] [Full Text] [PDF]

				P. Salvati, R. Maj, C. Caccia, M. A. Cervini, M. G. Fornaretto, E. Lamberti, P. Pevarello, G. A. Skeen, H. S. White, H. H. Wolf, et al. Biochemical and Electrophysiological Studies on the Mechanism of Action of PNU-151774E, A Novel Antiepileptic Compound J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1151 - 1159. [Abstract] [Full Text]

				R. A. Gross and W. H. Theodore ""The seat of the discharge"" and the molecules that govern seizures Neurology, February 1, 1999; 52(3): 441 - 441. [Full Text]

				C.-C. Kuo A Common Anticonvulsant Binding Site for Phenytoin, Carbamazepine, and Lamotrigine in Neuronal Na+ Channels Mol. Pharmacol., October 1, 1998; 54(4): 712 - 721. [Abstract] [Full Text]

				M. W. Hill, P. A. Reddy, D. F. Covey, and S. M. Rothman Inhibition of Voltage-Dependent Sodium Channels by the Anticonvulsant gamma -Aminobutyric Acid Type A Receptor Modulator, 3-Benzyl-3-Ethyl-2-Piperidinone J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1303 - 1309. [Abstract] [Full Text]

				I. Lampl, P. Schwindt, and W. Crill Reduction of Cortical Pyramidal Neuron Excitability by the Action of Phenytoin on Persistent Na+ Current J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 228 - 237. [Abstract] [Full Text]

				M. M. Segal and A. F. Douglas Late Sodium Channel Openings Underlying Epileptiform Activity Are Preferentially Diminished by the Anticonvulsant Phenytoin J Neurophysiol, June 1, 1997; 77(6): 3021 - 3034. [Abstract] [Full Text] [PDF]

				S. K. Norris and A. E. King J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1191 - 1198. [Abstract] [Full Text]

				C.-C. Kuo, R.-S. Chen, L. Lu, and R.-C. Chen Carbamazepine Inhibition of Neuronal Na+ Currents: Quantitative Distinction from Phenytoin and Possible Therapeutic Implications Mol. Pharmacol., June 1, 1997; 51(6): 1077 - 1083. [Abstract] [Full Text]

				A. W. Wamil, W. Löscher, and M. J. McLean Trans-2-en-valproic Acid Limits Action Potential Firing Frequency in Mouse Central Neurons in Cell Culture J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1349 - 1356. [Abstract] [Full Text]

				R. A. Gross, D. F. Covey, and J. A. Ferrendelli Voltage-Dependent Calcium Channels as Targets for Convulsant and Anticonvulsant Alkyl-Substituted Thiobutyrolactones J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 686 - 694. [Abstract] [Full Text]